GlassScriptPhysician profile
Dean L Zincone
NPI 1043208184
$230,112.14
in general payments reported to CMS, 2019-2025
45 companies · $879 in 2025
The $879 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221K · 2020: $1,121 · 2021: $2,068 · 2022: $1,785 · 2023: $1,600 · 2024: $1,686 · 2025: $879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,164.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $219,648.00 | 2019 | |
| Abbott Laboratories | $2,225.18 | 2019-2024 | Freestyle Libre 3, Gallant, Proclaim |
| Biosense Webster, INC. | $1,906.37 | 2022-2025 | Carto 3 |
| Atricure, INC. | $636.97 | 2021 | |
| Vertos Medical, INC. | $632.46 | 2022-2024 | Mild Device Kit |
| Janssen Pharmaceuticals, INC | $569.79 | 2019-2024 | Xarelto |
| Nestle Healthcare Nutrition INC. | $432.64 | 2020-2023 | |
| Astrazeneca Pharmaceuticals LP | $353.79 | 2019-2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $331.22 | 2020-2022 | |
| Bolton Medical INC | $296.15 | 2024-2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Gelweave, Metacross Otw |
| Lilly USA, LLC | $269.67 | 2021-2025 | Mounjaro, Zepbound |
| Aimmune Therapeutics, INC. | $268.16 | 2024-2025 | Zenpep |
| Phathom Pharmaceuticals, INC. | $205.83 | 2024-2025 | Voquezna |
| Glaxosmithkline, LLC. | $183.71 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Medtronic, INC. | $169.81 | 2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Zincone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.